Quick viewing(Text Mode)

Federal Register/Vol. 68, No. 68/Wednesday, April 9

Federal Register/Vol. 68, No. 68/Wednesday, April 9

17402 Federal Register / Vol. 68, No. 68 / Wednesday, April 9, 2003 / Notices

CONTESTING RECORD PROCEDURES: Drug Schedule registration of AccuStandard, Inc. to Individuals desiring to contest or manufacture the listed controlled amend information maintained in the (9051) ...... I substances is consistent with the public system should direct their request to the (9052) ...... I interest at this time. DEA has Office of the Assistant Attorney General, (9055) ...... I investigated AccuStandard, Inc. to methylbromide (9070) .... I ensure that the company’s registration is Civil Division, 950 Pennsylvania (9168) ...... I Avenue, NW., Washington, DC 20530. (9301) ...... I consistent with the public interest. This The request should clearly and (9304) ..... I investigation included inspection and concisely state what information is methylbromide (9305) .. I testing of the company’s physical being contested, the reason(s) for Morphine methylsulfonate (9306) I security systems, verification of the contesting it, and the proposed (9312) ...... I company’s compliance with state and amendment to the record. (9335) ...... I local laws, and a review of the (9602) ...... I company’s background and history. RECORD SOURCE CATEGORIES: (9605) ...... I Therefore, pursuant to 21 U.S.C. 823 Individuals submitting information Betaprodine (9611) ...... I (9612) ...... I and 28 CFR 0.100 and 0.104, the Deputy who are seeking to be included in the (9613) ...... I Assistant Administrator, Office of Department of Justice list of annuity (9615) ...... I Diversion Control, hereby orders that brokers. (9616) ...... I the application submitted by the above (9617) ...... I firm for registration as a bulk SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS (9618) ...... I OF THE ACT: manufacturer of the basic classes of (9619) ...... I controlled substances listed is granted. None. Dixoaphetyl butyrate (9621) ...... I Dated: March 21, 2003. [FR Doc. 03–8641 Filed 4–8–03; 8:45 am] (9622) ...... I (9623) .... I Laura M. Nagel, BILLING CODE 4410–12–P (9626) ...... I Deputy Assistant Administrator, Office of (9627) ...... I Diversion Control, Drug Enforcement (9628) ...... I Administration. DEPARTMENT OF JUSTICE (9632) ...... I [FR Doc. 03–8588 Filed 4–8–03; 8:45 am] (9633) ...... I Drug Enforcement Administration (9635) ...... I BILLING CODE 4410–09–M (9636) ...... I Manufacturer of Controlled (9637) ...... I Substances; Notice of Registration (9638) ...... I DEPARTMENT OF JUSTICE (9641) ...... I By Notice dated August 28, 2002, and (9642) ...... I Drug Enforcement Administration published in the Federal Register on (9643) ...... I October 18, 2002, (67 FR 64417), (9644) ...... I Manufacturer of Controlled AccuStandard, Inc., 125 Market Street, (9649) ...... I Substances; Notice of Application New Haven, Connecticut 06513, made 1-Methyl-4-phenyl-4- I Pursuant to § 1301.33(a) of Title 21 of application by letter to the Drug propionoxypiperidine (9661). 1-(2-Phenylethyl)-4-phenyl-4- I the Code of Federal Regulations (CFR), Enforcement Administration (DEA) to this is notice that on February 14, 2003, be registered as a bulk manufacturer of acetoxypiperidine (9663). (9750) ...... I Boehringer Ingelheim Chemicals, Inc., the basic classes of controlled Para-Fluorofentanyl (9812) ...... I 2820 N. Normandy Drive, Petersburg, substances listed below: 3-Methylfentanyl (9813) ...... I Virginia 23805, made application by Alpha-Methylfentanyl (9814) ...... I renewal, and on November 27, 2002, Drug Schedule Acetyl-alpha-methylfentanyl I made application by renewal, and on (9815). N=Ethylamphetamine (1475) ...... I November 27, 2002, made application Beta-Hydroxyfentanyl (9830) ...... I by letter to the Drug Enforcement N,N=Dimthylamphetamine (1480) I Beta-Hydroxy-3-methylfentanyl I Fenethylline (1503) ...... I (9831). Administration (DEA) for registration as Mecloqualone (2572) ...... I Alpha-Methylthiofentanyl (9832) ... I a bulk manufacturer of the basic classes Alpha-Ethyltryptamine (7249) ...... I 3-Methylthiofentanyl (9833) ...... I of controlled substances listed below: 3,4,5-Trimethoxyamphetamine I (9835) ...... I (7390). (7379) ...... II Drug Schedule 2,5-Dimethoxy-4- I 1-Phenylcylohexylamine (7460) ... II ethylamphetamine (7399). Phenylacetone (8501) ...... II Amphetamine (1100) ...... II 5-Methoxy-3,4- I 1- II (9250) ...... II methylenedioxyamphetamine Piperidinocyclohexanecarbonitr- Methadone-intermediate (9254) ... II (7401). ile (8603). Methylphenidate (1724) ...... II Diethyltryptamine (7434) ...... I (9226) ...... II Levo-aphacetylmethadol (9648) ... II Dimethyltryptamine (7435) ...... I (9260) ...... II (9801) ...... II Psilocybin (7437) ...... I (9730) ...... II Dextropropoxphene (9273) ...... II Psilocyn (7438) ...... I (9733) ...... II N-Ethyl-1-phenylcyclohexylamine I (9800) ...... II The firm plans to manufacture the (7455). listed controlled substances for 1-(1-Phenylcyclohexyl) pyrrolidine I The firm plans to manufacture small formulation into finished (PCPY) (7458). 1-[1-(2-Thienyl)cyclohexyl] pyrroli- I quantities of the listed controlled pharmaceuticals. dine (TCPY) (7473). substances to make reference standards. Any other such applicant and any N-Ethyl-3-piperidyl benzilate I No comments or objections have been person who is presently registered with (7482). received. DEA has considered the DEA to manufacture such substances N-Methyl-3-piperidyl benzilate I factors in Title 21, United States Code, may file comments or objections to the (7484). section 823(a) and determined that the issuance of the proposed registration.

VerDate Jan<31>2003 15:16 Apr 08, 2003 Jkt 200001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\09APN1.SGM 09APN1

Top View